NGC Update Service: September 18, 2017

NGC Update Service: September 18, 2017

Announcements

Semantic Vs. Full-text Searching Video Tutorial

Learn more about semantic searching vs. full-texting searching on the NGC Web site.

U.S. Food and Drug Administration (FDA) Advisory

September 6, 2017: Kayexalate (sodium polystyrene sulfonate): FDA is recommending that patients avoid taking the potassium-lowering drug sodium polystyrene sulfonate (Kayexalate) at the same time as other medicines taken by mouth. A study found that sodium polystyrene sulfonate binds to many commonly prescribed oral medicines, decreasing the absorption and therefore effectiveness of those oral medicines. To reduce this likelihood, FDA recommends separating the dosing of sodium polystyrene sulfonate from other orally administered medicines by at least 3 hours. FDA is updating the sodium polystyrene sulfonate drug labels to include information about this dosing separation.

Health Awareness Topics: September 2017

• Childhood Cancer Awareness Month (see related guidelines)
• National Atrial Fibrillation Awareness Month (see related guidelines)
• National Childhood Obesity Awareness Month (see related guidelines)
• National Sickle Cell Month (see related guidelines)
• National Traumatic Brain Injury Awareness Month (see related guidelines)
• Ovarian Cancer Awareness Month (see related guidelines)
• Prostate Cancer Awareness Month (see related guidelines)
• Sepsis Awareness Month (see related guidelines)

How to Participate

Submit Guidelines: Visit our Submit Guidelines page for information on how to submit your organization's guidelines.

Suggest a Guideline for Possible Inclusion: Submit your suggestions for evidence-based clinical practice guidelines that you would like to see included in NGC.